Loading company…
Riskpilot
← Back to search
Sign in
Get full access
OptimEyes Ögonvård AB
AB
Active
Org 5593465544
Ernst Josephsons Väg 20
Medical specialists activities · NACE 8622
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 192K
-31% vs 2024
EBITDA margin
94.5%
-26% vs 2024
Equity ratio
82.3%
Financial strength
Net profit 2025
SEK 163K
-18% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 192K
-31%
EBITDA
SEK 182K
-26%
Net profit
SEK 163K
-18%
Total assets
SEK 247K
-22%
Equity
SEK 203K
-15%
Employees
1
—
Company information
Legal name
OptimEyes Ögonvård AB
Org number
5593465544
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom ögonsjukvård samt medicinsk utbildning. Även konsult inom läkemedelsbranschen.
Contact
Address
Ernst Josephsons Väg 20
Email
daniel.kverneng.hultberg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
0
200
277
192
Staff expenses
—
−5
−5
−2
EBITDA
—
189
246
182
Depreciation & amort.
−0
—
—
—
EBIT
0
189
246
182
Net financials
—
2
3
19
Profit before tax
0
191
250
201
Tax
−0
−39
−51
−38
Net profit
0
152
198
163
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
25
251
316
247
Equity
25
177
240
203
Long-term debt
0
—
—
—
Short-term debt
0
74
76
44
Total debt
—
74
76
44
Financial ratios
5-year trend
EBITDA margin
94.5%
This company
15.8%
Market median
+498% vs market
2022
2025
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
2022
2025
Return on equity
80.3%
This company
18.4%
Market median
+336% vs market
2022
2025
Net profit margin
85.0%
This company
8.1%
Market median
+949% vs market
2022
2025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
2022
2025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DP
Daniel Peter Kverneng Hultberg
Board of Directors
2022
TP
Thor Peter Hultberg
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of OptimEyes Ögonvård AB also hold positions in
0
other companies.
Person
Role here
Other companies
Daniel Peter Kverneng Hultberg
Board of Directors
0 companies
Thor Peter Hultberg
Deputy Board Member
0 companies